Immutep Ltd has a consensus price target of $9 based on the ratings of 3 analysts. The high is $10 issued by Capital One on May 17, 2024. The low is $7 issued by Baird on November 15, 2024. The 3 most-recent analyst ratings were released by Baird, Baird, and Capital One on November 15, 2024, June 27, 2024, and May 17, 2024, respectively. With an average price target of $7.67 between Baird, Baird, and Capital One, there's an implied 299.31% upside for Immutep Ltd from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Immutep (NASDAQ:IMMP) was reported by Baird on November 15, 2024. The analyst firm set a price target for $7.00 expecting IMMP to rise to within 12 months (a possible 264.58% upside). 3 analyst firms have reported ratings in the last year.
The latest analyst rating for Immutep (NASDAQ:IMMP) was provided by Baird, and Immutep maintained their outperform rating.
There is no last upgrade for Immutep
There is no last downgrade for Immutep.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Immutep, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Immutep was filed on November 15, 2024 so you should expect the next rating to be made available sometime around November 15, 2025.
While ratings are subjective and will change, the latest Immutep (IMMP) rating was a maintained with a price target of $6.00 to $7.00. The current price Immutep (IMMP) is trading at is $1.92, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.